This work is powered by technology platforms that help us innovate across our core therapeutic areas: Cardiovascular, Renal and Metabolic, Oncology, Immunology, and Neuroscience. We focus on two established platforms – chemistry and biotherapeutics – as well as three advanced platforms – xRNA, radioligand therapy, and gene and cell therapy – we believe will continue to play an increasingly important role in delivering new medicines for patients.

calendar-IconSeptember 29 - November 20, 2024